vs
Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and MODIV INDUSTRIAL, INC. (MDV). Click either name above to swap in a different company.
MODIV INDUSTRIAL, INC. is the larger business by last-quarter revenue ($11.1M vs $7.8M, roughly 1.4× CRYO CELL INTERNATIONAL INC). MODIV INDUSTRIAL, INC. runs the higher net margin — 11.0% vs -48.7%, a 59.6% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -5.6%). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -3.8%).
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
MODIV INDUSTRIAL, INC. is a U.S.-based industrial real estate enterprise focused on acquiring, owning and operating high-quality industrial properties mainly located in key logistics and distribution hubs across North America. It serves tenants from sectors including e-commerce fulfillment, manufacturing and third-party logistics, addressing rising demand for modern supply chain infrastructure.
CCEL vs MDV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.8M | $11.1M |
| Net Profit | $-3.8M | $1.2M |
| Gross Margin | 77.9% | — |
| Operating Margin | -50.6% | 45.8% |
| Net Margin | -48.7% | 11.0% |
| Revenue YoY | -2.3% | -5.6% |
| Net Profit YoY | -105.1% | -22.0% |
| EPS (diluted) | $-0.46 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.8M | $11.1M | ||
| Q3 25 | $7.8M | $11.7M | ||
| Q2 25 | $7.9M | $11.8M | ||
| Q1 25 | $8.0M | $11.8M | ||
| Q4 24 | $8.0M | $11.7M | ||
| Q3 24 | $8.1M | $11.7M | ||
| Q2 24 | $8.0M | $11.4M | ||
| Q1 24 | $7.9M | $12.0M |
| Q4 25 | $-3.8M | $1.2M | ||
| Q3 25 | $749.4K | $1.0M | ||
| Q2 25 | $355.8K | $-2.0M | ||
| Q1 25 | $282.9K | $829.0K | ||
| Q4 24 | $-1.9M | $1.6M | ||
| Q3 24 | $1.1M | $-587.0K | ||
| Q2 24 | $655.8K | $1.3M | ||
| Q1 24 | $556.2K | $3.7M |
| Q4 25 | 77.9% | — | ||
| Q3 25 | 77.0% | — | ||
| Q2 25 | 76.6% | — | ||
| Q1 25 | 75.1% | — | ||
| Q4 24 | 78.4% | — | ||
| Q3 24 | 73.6% | — | ||
| Q2 24 | 74.8% | — | ||
| Q1 24 | 73.7% | — |
| Q4 25 | -50.6% | 45.8% | ||
| Q3 25 | 24.3% | 41.4% | ||
| Q2 25 | 18.8% | 9.8% | ||
| Q1 25 | 13.3% | 40.2% | ||
| Q4 24 | -1.5% | 45.4% | ||
| Q3 24 | 17.2% | 42.0% | ||
| Q2 24 | 17.3% | 44.6% | ||
| Q1 24 | 10.5% | 55.6% |
| Q4 25 | -48.7% | 11.0% | ||
| Q3 25 | 9.6% | 9.0% | ||
| Q2 25 | 4.5% | -17.1% | ||
| Q1 25 | 3.5% | 7.0% | ||
| Q4 24 | -23.2% | 13.3% | ||
| Q3 24 | 13.0% | -5.0% | ||
| Q2 24 | 8.2% | 11.6% | ||
| Q1 24 | 7.1% | 31.1% |
| Q4 25 | $-0.46 | $0.02 | ||
| Q3 25 | $0.09 | $0.00 | ||
| Q2 25 | $0.04 | $-0.32 | ||
| Q1 25 | $0.03 | $-0.01 | ||
| Q4 24 | $-0.23 | $0.07 | ||
| Q3 24 | $0.13 | $-0.18 | ||
| Q2 24 | $0.08 | $0.03 | ||
| Q1 24 | $0.07 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.3M | $14.4M |
| Total DebtLower is stronger | $8.4M | $261.5M |
| Stockholders' EquityBook value | $-18.6M | $162.7M |
| Total Assets | $61.7M | $476.5M |
| Debt / EquityLower = less leverage | — | 1.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.3M | $14.4M | ||
| Q3 25 | $3.2M | $8.3M | ||
| Q2 25 | $4.4M | $5.8M | ||
| Q1 25 | $3.5M | $6.2M | ||
| Q4 24 | $3.5M | $11.5M | ||
| Q3 24 | $2.1M | $6.8M | ||
| Q2 24 | $1.5M | $18.9M | ||
| Q1 24 | $979.6K | $18.4M |
| Q4 25 | $8.4M | $261.5M | ||
| Q3 25 | $8.4M | $279.7M | ||
| Q2 25 | $8.4M | $279.7M | ||
| Q1 25 | $8.5M | $279.7M | ||
| Q4 24 | $8.5M | $279.8M | ||
| Q3 24 | $8.5M | $279.7M | ||
| Q2 24 | $8.5M | $279.7M | ||
| Q1 24 | $8.6M | $279.6M |
| Q4 25 | $-18.6M | $162.7M | ||
| Q3 25 | $-14.8M | $164.8M | ||
| Q2 25 | $-15.6M | $165.6M | ||
| Q1 25 | $-14.7M | $171.1M | ||
| Q4 24 | $-13.2M | $190.1M | ||
| Q3 24 | $-9.6M | $186.3M | ||
| Q2 24 | $-10.7M | $187.0M | ||
| Q1 24 | $-10.3M | $188.0M |
| Q4 25 | $61.7M | $476.5M | ||
| Q3 25 | $63.2M | $499.6M | ||
| Q2 25 | $64.4M | $498.9M | ||
| Q1 25 | $64.4M | $506.8M | ||
| Q4 24 | $64.7M | $507.8M | ||
| Q3 24 | $62.9M | $507.4M | ||
| Q2 24 | $62.6M | $519.5M | ||
| Q1 24 | $61.7M | $522.5M |
| Q4 25 | — | 1.61× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.69× | ||
| Q1 25 | — | 1.63× | ||
| Q4 24 | — | 1.47× | ||
| Q3 24 | — | 1.50× | ||
| Q2 24 | — | 1.50× | ||
| Q1 24 | — | 1.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.3M | $15.0M |
| Free Cash FlowOCF − Capex | $1.2M | — |
| FCF MarginFCF / Revenue | 15.5% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | 12.34× |
| TTM Free Cash FlowTrailing 4 quarters | $5.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.3M | $15.0M | ||
| Q3 25 | $2.5M | $4.1M | ||
| Q2 25 | $707.0K | $3.9M | ||
| Q1 25 | $954.1K | $3.0M | ||
| Q4 24 | $2.2M | $18.2M | ||
| Q3 24 | $2.4M | $5.1M | ||
| Q2 24 | $1.8M | $4.7M | ||
| Q1 24 | $-356.9K | $3.0M |
| Q4 25 | $1.2M | — | ||
| Q3 25 | $2.5M | — | ||
| Q2 25 | $644.6K | — | ||
| Q1 25 | $892.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.3M | — | ||
| Q2 24 | $21.5K | — | ||
| Q1 24 | $-814.6K | — |
| Q4 25 | 15.5% | — | ||
| Q3 25 | 31.9% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 11.2% | — | ||
| Q4 24 | 26.8% | — | ||
| Q3 24 | 27.9% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | -10.4% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 21.8% | — | ||
| Q1 24 | 5.8% | — |
| Q4 25 | — | 12.34× | ||
| Q3 25 | 3.38× | 3.95× | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 3.37× | 3.68× | ||
| Q4 24 | — | 11.72× | ||
| Q3 24 | 2.32× | — | ||
| Q2 24 | 2.70× | 3.55× | ||
| Q1 24 | -0.64× | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
